In the case that the cancer cells acquire resistance to ADT as CRPC, however, the expression of HS3ST1 and 3-OS HS is upregulated, facilitating the binding of EGF and HB-EGF to EGFR via 3-OS HS. The gene discussed is EGFR; the disease is cancer.